Discontinue use if paradoxical bronchospasm occurs. Not to be used for initial management of asthma. Not to be initiated during exacerbation or in patients w/ significantly worsening or acutely deteriorating asthma. Pneumonia in patients w/ COPD. Cushing's syndrome, Cushingoid features, adrenal suppression, decreased bone mineral density, cataract, glaucoma, psychomotor hyperactivity, sleep disorders, anxiety, depression or aggression. Active or quiescent pulmonary TB, fungal & viral airway infections; cardiac arrhythmias especially 3rd degree AV block, tachyarrhythmias, idiopathic subvalvular aortic stenosis, hypertrophic obstructive cardiomyopathy, ischaemic heart disease, severe heart failure, arterial HTN, aneurysm; known or suspected QTc interval prolongation; thyrotoxicosis, DM, phaeochromocytoma, untreated hypokalaemia; unstable asthma. May cause allergic reactions due to lactose. Risk of oropharyngeal fungal infections & dysphonia. Monitor serum K & blood glucose levels. Transferring patients from oral to inhaled corticosteroids. Avoid abrupt w/drawal. High-dose & prolonged use. Not to be administered for at least 12 hr prior to anaesth. Concomitant use w/ xanthine derivatives, steroids, diuretics. Not recommended during pregnancy. Lactation. Growth retardation in childn & adolescents <18 yr.